Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 143.8 M148.8 M147.3 M141.9 M144.2 M153.8 M 587.2 M Research & development —————— — Operating income 69.8 M101 M106.8 M108.8 M57.6 M94.6 M 367.8 M Non-Operating Income, Total -200 K700 K400 K1.4 M-200 K1 M 2.6 M Interest expense, net of interest capitalized 8.3 M8.3 M6.9 M8.2 M10.3 M10.5 M 35.9 M Non-Operating Income, excl. Interest Expenses -8.3 M-8.3 M-6.9 M-8.2 M-10.3 M-10.5 M -35.9 M Unusual income/expense -200 K700 K400 K1.4 M-200 K1 M 2.6 M Pretax income 61.3 M93.4 M100.3 M102 M47.1 M85.1 M 334.5 M Equity in earnings —————— — Taxes 15.9 M24.4 M25.9 M25.4 M12.3 M20.2 M 83.8 M Non-controlling/minority interest —————— — After tax other income/expense 2.4 M3.2 M3.4 M3.1 M1.7 M1.8 M 10 M Net income before discontinued operations 45.4 M69 M74.4 M76.6 M34.8 M64.9 M 250.7 M Discontinued operations —————— — Net income 45.4 M69 M74.4 M76.6 M34.8 M64.9 M 250.7 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 45.4 M69 M74.4 M76.6 M34.8 M64.9 M 250.7 M Basic earnings per share (Basic EPS) 1.652.532.752.831.32.44 9.32 Diluted earnings per share (Diluted EPS) 1.642.522.742.811.292.43 9.27 Average basic shares outstanding 27.52 M27.32 M27.07 M27.2 M26.8 M26.63 M — Diluted shares outstanding 27.7 M27.4 M27.17 M27.33 M26.97 M26.71 M — EBITDA 85 M116.2 M122.1 M124.5 M73.9 M111.1 M 431.6 M EBIT 69.8 M101 M106.8 M108.8 M57.6 M94.6 M 367.8 M Cost of revenue 461.1 M500.4 M514 M486 M448.2 M518.9 M 1.97 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 15.2 M15.2 M15.3 M15.7 M16.3 M16.5 M 63.8 M